Lastly, the concomitant increase in the gene transcripts of protease inhibitors, TIMP1, TIMP3, and SERPINE1, suggest that CaSR may facilitate a profibrotic environment promoting a non-degrading collagen-rich ECM, which is a defining feature of human and animal models of lung fibrosis [86,87]. This evidence concerns the gene CASR and pulmonary fibrosis.